4.6 Review

Prosthetic Joint Infection

Journal

CLINICAL MICROBIOLOGY REVIEWS
Volume 27, Issue 2, Pages 302-345

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/CMR.00111-13

Keywords

-

Categories

Funding

  1. Astellas
  2. Tornier
  3. Pocared
  4. Pradama
  5. Pfizer
  6. 3M
  7. BioFire
  8. nanoMR
  9. National Institutes of Health [R01 AR 056647, R01 AI 91594]

Ask authors/readers for more resources

Prosthetic joint infection (PJI) is a tremendous burden for individual patients as well as the global health care industry. While a small minority of joint arthroplasties will become infected, appropriate recognition and management are critical to preserve or restore adequate function and prevent excess morbidity. In this review, we describe the reported risk factors for and clinical manifestations of PJI. We discuss the pathogenesis of PJI and the numerous microorganisms that can cause this devastating infection. The recently proposed consensus definitions of PJI and approaches to accurate diagnosis are reviewed in detail. An overview of the treatment and prevention of this challenging condition is provided.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available